Evidence map›Paper›PMID 38336743›Full record

ArticleJournal of cardiothoracic surgery2024

Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation.

Freya Sophie Jenkins, Jan-Philipp Minol, Tarik Akar, Esma Yilmaz, Moritz Benjamin Immohr, Ismail Dalyanoglu, Bernhard Korbmacher, Joel Aissa, Udo Boeken, Artur Lichtenberg and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiothoracic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Freya Sophie JenkinsDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Jan-Philipp MinolDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. philipp.minol@gmail.com.
Tarik AkarDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Esma YilmazDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Moritz Benjamin ImmohrDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Ismail DalyanogluMedical Faculty, Semmelweiss University, Budapest, Hungary.
Bernhard KorbmacherDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Joel AissaInstitute of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Udo BoekenDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Artur LichtenbergDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Payam AkhyariDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Hannan DalyanogluDepartment of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DESemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeft ventricular assist devices (LVAD) are an established treatment for end-stage left ventricular heart failure. Parameters are needed to identify the most appropriate patients for LVADs. This study aimed to evaluate pectoral muscle mass and density as prognostic parameters.

methodsThis single-center study included all patients with LVAD implantation between January 2010 and October 2017 and a preoperative chest CT scan. Pectoral muscle mass was assessed using the Pectoralis Muscle Index (PMI, surface area indexed to height, cm

results57 patients (89.5% male, mean age 57.8 years) were included. 64.9% of patients had end-stage left ventricular failure due to ischemic heart disease and 35.1% due to dilated cardiomyopathy. 49.2% of patients had preoperative INTERMACS profile of 1 or 2 and 33.3% received mechanical circulatory support prior to LVAD implantation. Total mean PMI was 4.7 cm

conclusionsThe results of our study do not confirm the association between higher pectoral muscle mass and better survival after LVAD implantation previously described in the literature.

Indexed as

Heart-Assist DevicesHeart FailureFemaleHumansMaleMiddle AgedPectoralis MusclesPrognosisRetrospective StudiesTreatment OutcomeFrailtyLeft ventricular assist deviceLeft ventricular heart failurePectoral muscle mass

Identifiers

PMID38336743
PMCPMC10858520
OpenAlexW4391682303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.